‘Storm Of Change’ Could Propel Industry On Making Daily Oral Contraceptive Available OTC In US 2022, Media / By lsc-webmaster
U.S. abortion ruling ignites retail interest in women contraceptive makers 2022, Media / By lsc-webmaster
With Roe overturned, Femasys’ permanent contraception has increased appeal 2022, Media / By lsc-webmaster
What do you consider the biggest challenge that the pharma/biopharma industry currently faces? 2022, Media / By lsc-webmaster
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations? 2022, Media / By lsc-webmaster
CEO & Founder of Femasys, Kathy Lee-Sepsick, on Leading in Women’s Health Tech for 18 Years 2022, Media / By lsc-webmaster
